IP Library › Granted Patent US 9,717,773
Granted Patent B2
US 9,717,773 · App. 15/045,709 · Granted Aug 1, 2017

Lactococcus lactis strains for producing bioactive peptides having anti-hypertensive and cholesterol-lowering effects

Inventors: Belinda Vallejo Galland (Hermosillo, MX); Aarón Fernando González Córdova (Hermosillo, MX); Jóse Carlos Rodriguez Figueroa (Hermosillo, MX)
Assignees: CENTRO DE INVESTIGACION EN ALIMENTACION Y DESARROLLO, A.C. (CIAD); VALLEJO GALLAND, BELINDA; CORDOVA, AARON FERNANDO GONZALES
A61K38/08A23C9/123A23C9/1234A23C9/152A23C9/1526A23L2/382A23L2/52A23L33/135A61K9/0053A61K9/0095A61K35/74A61K35/742A61K35/744A61K38/10C12N1/20C12P21/00C12P21/06C12R1/00C12R1/01A23V2002/00A23Y2240/41A61K2035/115
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,717,773
App. No.
15/045,709
Granted
Aug 1, 2017
Kind
B2
Abstract

New Lactococcus lactis strains, NRRL B-50571 and NRRL B-50572, and a bacterial preparation containing the same, have the ability to produce bioactive peptides that reduce blood pressure, lower LDL-cholesterol (bad cholesterol) and present antioxidant properties for better cardiovascular health. These biologically active peptides may be produced within the food for the production of a food product, such as a functional food, or they may be produced from protein sources and subsequently added to a food as part of the formulation or as part of a food supplement or a pharmaceutical preparation.

Claims (8)

1. A method of lowering low density lipoproteins (LDL) in the blood of a hypertensive subject in need thereof, comprising administering to the subject a composition comprising a therapeutically effective amount of a fermented milk or fermented milk-based product, wherein the product is made by fermenting a milk or milk-based starting material with Lactococcus lactis strain NRRL B-50571.

2. The method of claim 1 , further comprising the step of removing unhydrolyzed protein from the fermented milk or fermented milk-based product after the fermentation step.

3. The method of claim 1 , wherein the starting material is milk.

4. The method of claim 1 , wherein the starting material is a milk-based product.

5. A method of lowering blood pressure in a hypertensive subject in need thereof, comprising administering to the subject a composition comprising a therapeutically effective amount of a fermented milk or fermented milk-based product, wherein the product is made by fermenting a milk or milk-based starting material with Lactococcus lactis strain NRRL B-50571.

6. The method of claim 5 , further comprising the step of removing unhydrolyzed protein from the fermented milk or fermented milk-based product after the fermentation step.

7. The method of claim 5 , wherein the starting material is milk.

8. The method of claim 5 , wherein the starting material is a milk-based product.

Continuity (4)
Continuation 14509925 · Oct 8, 2014
Division 13629398 · Sep 27, 2012
Provisional Application 61540979 · Sep 29, 2011
Related Publication 20160158296A1 · Jun 9, 2016